CVS Health names Aetna’s Kathryn Metcalfe as chief communications officer
Aetna’s comms leader has moved into the top comms spot of the newly combined entity.
Aetna’s comms leader has moved into the top comms spot of the newly combined entity.
Public trust in the pharma industry has taken a dip, according to recent data. Do actual patients agree?
As with most drug pricing battles, patients yet again are caught in the crossfire.
With pharma facing ongoing scrutiny of its pricing practices, medical marketers are increasingly asked to demonstrate the superior value of new therapies. High-profile candidates in immunology, pain management, and melanoma challenge marketers well in advance of launch.
Details are vague, but the e-commerce giant indicated it’s serious about getting into healthcare.
Senate committee votes in favor of Azar as new HHS head; FDA and DoD launch breakthrough designation program; Walmart offers free opioid disposal solution
Merck’s Keytruda combo therapy succeeds in Phase-III lung cancer trial; FDA launches pilot to address trial transparency; Spark’s Luxturna overpriced, ICER says
Roche to buy Ignyta for $1.7 billion; FDA OKs Valeant eye drop for OTC sale; Kmart settles prescription drug fraud allegations
Pharma industry spent $57 million on lobbying in 2016; Humana, private equity firms to buy Kindred for $4 billion; price of old glaucoma drug skyrockets
CVS/Aetna deal will affect healthcare benefits; lawmakers pressure DEA to curb painkiller supply; Allergan and Richter’s Vraylar sees positive results for bipolar depression